The effect of tyrosine kinase inhibitors used in the treatment of chronic myeloid leukemia on the cardiovascular system The effect of tyrosine kinase inhibitors used in the treatment of chronic myeloid leukemia on the cardiovascular system

Tomasz Sacha, Joanna Góra-Tybor, Sebastian Szmit

OncoReview 2019; 1(33): 3-21. DOI: 10.24292/01.OR.119210219

Cardiac complications during DLBCL treatment using R-CHOP Cardiac complications during DLBCL treatment using R-CHOP

Barbara Sosnowska-Pasiarska, Paweł Zgódka, Paulina Steckiewicz, Marcin Pasiarski

OncoReview 2019; 1(33): 22-26. DOI: 10.24292/01.OR.119080319

Severe vascular and neurological complications after hematopoietic stem cell transplantation with reduced intensity conditioning Severe vascular and neurological complications after hematopoietic stem cell transplantation with reduced intensity conditioning

Krzysztof Czyżewski, Paulina Nierychlewska, Monika Richert-Przygońska, Jakub Cieściński, Jan Styczyński

OncoReview 2019; 1(33): DOI: 27-30. DOI: 10.24292/01.OR.119190219

Navigating the treatment landscape in gastroenteropancreatic neuroendocrine neoplasms Navigating the treatment landscape in gastroenteropancreatic neuroendocrine neoplasms

Wojciech Rogowski, Ewa Wachuła, Violetta Sulżyc-Bielicka

OncoReview 2019; 1(33): 31-39. DOI: 10.24292/01.OR.119200219